Movement Enhancing Device for Children

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-31

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess: 1) how infants move their bodies to explore, play, and solve problems, 2) if this is different in a high-risk group of infants, and 3) if these abilities can be advanced in a high-risk group through the use of a movement assisting device.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sensorimotor Control During Postural Transitions in CP

NCT05384990

Cerebral Palsy

ACTIVE_NOT_RECRUITING NA

Motor Training for Infants With Cerebral Palsy

NCT04886895

Cerebral Palsy

RECRUITING NA

Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy

NCT06455930

Cerebral Palsy

RECRUITING EARLY_PHASE1

Mobility Training to Improve Motor Behavior in Toddlers With or at Risk for Cerebral Palsy: A Pilot Study

NCT01253083

Developmental Delay Cerebral Palsy

COMPLETED PHASE1

A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia

NCT06579027

Hemiplegia Cerebral Palsy Children, Only

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Certain conditions or diagnoses identified soon after birth are known to put infants at risk for having problems with their motor (movement) development as they get older. Infants with these diagnoses are at risk for additional developmental problems due to their inability to move their bodies to explore, learn, and play. This study tests how a device that assists movement can help exploration, learning, and play in children. The information gathered in this study will help us better understand how early learning happens and how we can help individuals become better movers, learners, and problem-solvers so they can increase their participation in everyday play activities.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Extremity Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Coders are blind to which study phase participants are in

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Movement enhancing device

Guided play while wearing a movement assisting device

Group Type OTHER

Movement Enhancing Device

Intervention Type DEVICE

Naturalistic play activities using the hands while wearing the movement enhancing device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Movement Enhancing Device

Naturalistic play activities using the hands while wearing the movement enhancing device.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

WREX (Wilmington Robotic Exoskeleton)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Infants will be invited to participate if they are between 1 month and 6 years and:

* Were born \< 36 weeks of gestational age with periventricular leukomalacia or grade III or IV intraventricular hemorrhage
* Were born \> 36 weeks of gestational age with encephalopathy related to perinatal asphyxia
* Have the diagnosis of neonatal stroke or intracranial hemorrhage
* Have brachial plexus palsy
* Have arthrogryposis multiplex congenital
* Have Down syndrome
* Have congenital hypotonia